$8.33
0.95%
Nasdaq, Nov 14, 10:06 pm CET
ISIN
US15687V1098
Symbol
CERT

Certara Stock price

$8.33
-3.57 30.00% 1M
-3.39 28.92% 6M
-2.32 21.78% YTD
-2.20 20.89% 1Y
-6.31 43.10% 3Y
-29.75 78.13% 5Y
-29.75 78.13% 10Y
-29.75 78.13% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
-0.08 0.95%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.4b
Net debt
$120.8m
Cash
$172.7m
Shares outstanding
159.4m
Valuation (TTM | estimate)
P/E
119.0 | 18.7
P/S
3.2 | 3.1
EV/Sales
3.5 | 3.4
EV/FCF
15.8
P/B
1.3
Financial Health
Equity Ratio
67.2%
Return on Equity
-1.1%
ROCE
1.9%
ROIC
1.8%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$415.6m | $430.2m
EBITDA
$82.3m | $134.5m
EBIT
$26.2m | $120.8m
Net Income
$10.9m | $71.1m
Free Cash Flow
$91.5m
Growth (TTM | estimate)
Revenue
11.5% | 11.7%
EBITDA
131.6% | 159.4%
EBIT
261.6% | 7,084.4%
Net Income
135.0% | 689.8%
Free Cash Flow
162.6%
Margin (TTM | estimate)
Gross
61.4%
EBITDA
19.8% | 31.3%
EBIT
6.3%
Net
2.6% | 16.5%
Free Cash Flow
22.0%
More
EPS
$0.1
FCF per Share
$0.6
Short interest
14.9%
Employees
2k
Rev per Employee
$250.0k
Show more

Is Certara a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Certara Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Certara forecast:

11x Buy
61%
7x Hold
39%

Analyst Opinions

18 Analysts have issued a Certara forecast:

Buy
61%
Hold
39%

Financial data from Certara

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
416 416
11% 11%
100%
- Direct Costs 160 160
7% 7%
39%
255 255
15% 15%
61%
- Selling and Administrative Expenses 136 136
9% 9%
33%
- Research and Development Expense 38 38
0% 0%
9%
82 82
132% 132%
20%
- Depreciation and Amortization 56 56
8% 8%
13%
EBIT (Operating Income) EBIT 26 26
262% 262%
6%
Net Profit 11 11
135% 135%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Certara directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Certara Stock News

Neutral
Seeking Alpha
10 days ago
Certara, Inc. ( CERT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants David Deuchler - Gilmartin Group LLC Daniel Christopher Clark - Leerink Partners LLC, Research Division David Windley - Jefferies LLC, Research Division Matthew He...
Neutral
GlobeNewsWire
11 days ago
RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025.
Neutral
GlobeNewsWire
13 days ago
RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module of its Phoenix Cloud solution.
More Certara News

Company Profile

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Head office United States
CEO William Feehery
Employees 1,517
Founded 2008
Website www.certara.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today